Longitudinal trajectory of acidosis and mortality in acute kidney injury requiring continuous renal replacement therapy

BMC Nephrol. 2022 Dec 26;23(1):411. doi: 10.1186/s12882-022-03047-4.

Abstract

Background: Acidosis frequently occurs in severe acute kidney injury (AKI), and continuous renal replacement therapy (CRRT) can control this pathologic condition. Nevertheless, acidosis may be aggravated; thus, monitoring is essential after starting CRRT. Herein, we addressed the longitudinal trajectory of acidosis on CRRT and its relationship with worse outcomes.

Methods: The latent growth mixture model was applied to classify the trajectories of pH during the first 24 hours and those of C-reactive protein (CRP) after 24 hours on CRRT due to AKI (n = 1815). Cox proportional hazard models were used to calculate hazard ratios of all-cause mortality after adjusting multiple variables or matching their propensity scores.

Results: The patients could be classified into 5 clusters, including the normally maintained groups (1st cluster, pH = 7.4; and 2nd cluster, pH = 7.3), recovering group (3rd cluster with pH values from 7.2 to 7.3), aggravating group (4th cluster with pH values from 7.3 to 7.2), and ill-being group (5th cluster, pH < 7.2). The pH clusters had different trends of C-reactive protein (CRP) after 24 hours; the 1st and 2nd pH clusters had lower levels, but the 3rd to 5th pH clusters had an increasing trend of CRP. The 1st pH cluster had the best survival rates, and the 3rd to 5th pH clusters had the worst survival rates. This survival difference was significant despite adjusting for other variables or matching propensity scores.

Conclusions: Initial trajectories of acidosis determine subsequent worse outcomes, such as mortality and inflammation, in patients undergoing CRRT due to AKI.

Keywords: Acidosis; Acute kidney injury; Continuous renal replacement therapy; Inflammation; Mortality.

MeSH terms

  • Acidosis*
  • Acute Kidney Injury* / therapy
  • C-Reactive Protein
  • Continuous Renal Replacement Therapy*
  • Critical Illness / therapy
  • Humans
  • Renal Replacement Therapy
  • Retrospective Studies

Substances

  • C-Reactive Protein